Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Paraninfo, G"'
Autor:
Casari, S., Donisi, A., Paraninfo, G., Tomasoni, D., Palvarini, L., Nasta, P., Bergamasco, A., Cadeo, G. P., Carosi, G.
Publikováno v:
European Journal of Epidemiology, 1999 Sep 01. 15(8), 691-698.
Externí odkaz:
https://www.jstor.org/stable/3582203
Autor:
Torti, C., Prosperi, M., Motta, D., Digiambenedetto, S., Maggiolo, F., Paraninfo, G., Ripamonti, D., Cologni, G., Fabbiani, M., Caputo, S.L., Sighinolfi, L., Ladisa, N., El-Hamad, I., Quiros-Roldan, E., Frank, I.
Publikováno v:
In Clinical Microbiology and Infection May 2012 18(5):449-458
Autor:
Quiros-Roldan, E., Magro, P., Raffetti, E., Izzo, I., Borghetti, Alberto, Lombardi, Francesca, Saracino, A., Maggiolo, F., Castelli, F., Carosi, Giulia, Paraninfo, G. E., Torti, Carlo, Cauda, Roberto, Di Giambenedetto, Simona, Fabbiani, M., Colafigli, Manuela, Scalzini, A., Castelnuovo, F., El Hamad, I., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Di Pietro, Maria Luisa, Ble, C., Vichi, F., Sighinolfi, L., Angarano, G., Ladisa, N., Monno, L., Maggi, P., Pan, A., Costarelli, S., Gori, A., Lapadula, G., Puoti, M., Viale, P., Colangeli, V., Borderi, M.
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Infectious Diseases
BMC Infectious Diseases
Background Triple-drug regimens are the gold standard for HIV therapy. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to decrease drugs toxicity, exposure and costs. Aim of our study was to evaluate trends of bioche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce011037cf15a4e3d28417b3db7e01ff
http://hdl.handle.net/10807/193903
http://hdl.handle.net/10807/193903
Autor:
Torti, C., Bono, L., Gargiulo, F., Uccelli, M.C., Quiros-Roldan, E., Patroni, A., Paraninfo, G., Tirelli, V., Manca, N., De Francesco, M.A., Perandin, F., Carosi, G.
Publikováno v:
In Clinical Microbiology and Infection September 2004 10(9):826-830
Autor:
LAPADULA, GIUSEPPE, GORI, ANDREA, Chatenoud, L, Castelli, F, Di Giambenedetto, S, Fabbiani, M, Maggiolo, F, Focà, E, Ladisa, N, Sighinolfi, L, Di Pietro, M, Pan, A, Torti, C, Carosi, G, Quiros, E, Nasta, P, Paraninfo, G, Cauda, R, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Pierotti, P, Marino, N, Blè, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Costarelli, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M.
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124741 (2015)
PLoS ONE
PLoS ONE
Background: Immunological non-response (INR) despite virological suppression is associated with AIDS-defining events/death (ADE). Little is known about its association with serious non-AIDS-defining events (nADE). Methods Patients highly-active antir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140029a5332ee002722b8f4ccfe00a49
http://hdl.handle.net/10807/68423
http://hdl.handle.net/10807/68423
Autor:
Postorino, Maria Concetta, Quiros Roldan, Eugenia, Maggiolo, Franco, Di Giambenedetto, Simona, Ladisa, Nicoletta, Lapadula, Giuseppe, Lorenzotti, Silvia, Sighinolfi, Laura, Castelnuovo, Filippo, di Pietro, Massimo, Gotti, Daria, Mazzini, Nicola, Torti, Carlo, Castelli, F., Carosi, G., Nasta, P., Paraninfo, G., Focà, E., di Giambenedetto, R. Cauda S., Fabbiani, Massimiliano, Colafigli, Manuela, Scalzini, A., El Hamad, I., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Monno, L., Maggi, P., Pan, A., Costarelli, S., Gori, A., Lapadula, G., Puoti, M., Viale, P., Colangeli, V., Borderi, M.
Publikováno v:
The Open AIDS Journal
Background and Objectives: Renal toxicity due to tenofovir (TDF) has been largely described in patients with HIV infection. However, other antiretroviral drugs (such as atazanavir [ATV], especially when boosted by ritonavir, ATV/r) could perpetuate s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66f79f0a8c7f0ddcd37f34bdefaced2f
http://hdl.handle.net/10807/94835
http://hdl.handle.net/10807/94835
Autor:
Puoti, M., Cadeo, G.P., Putzolu, V., Forleo, M.A., Barni, M.C., Cristini, G., Rossi, S., Spinetti, A., Zaltron, S., Zanini, B., Quiros-Roldan, E., Paraninfo, G., Gargiulo, F., Carosi, G.
Publikováno v:
In Digestive and Liver Disease 2001 33(2):163-172
Autor:
Tarkowski, M., Ferraris, L., Martone, S., Strambio De Castillia, F., Misciagna, D., Mazzucchelli, R. I., Lattuada, E., Paraninfo, G., Galli, M., Riva, A. the ELVIS Study., Aquaro S, Di Biagio A., Cossarizza, A, D'Offizi, G, Poli, G, Vicenzi, E, Carosi, G, Sciandra, M, Quinzan, G, Suter, F, Concia, E, Rossi, Gb, Beretta, R, Fasolo, M, Meraviglia, P, Magni, C, Capetti, A, Rizzardini, G, Mazzotta, F, Di Pietro, M, Vacca, Eb, Di Biagio, A, Viscoli, C, Colombo, C, Cappelletti, A.
Publikováno v:
AIDS Research and Human Retroviruses. 28:693-701
Interleukin-15 (IL-15) enhances the effector mechanisms of anti-HIV immune responses and thus is considered a potential adjuvant of HIV-1 vaccine. However, there are a lack of data concerning the relationships between IL-15 expression and regulation
Autor:
Tarkowski M, Ferraris L, Martone S, Strambio de Castillia F, Misciagna D, Mazzucchelli RI, Lattuada E, Paraninfo G, Galli M, Riva A, Elvis Study Group, POLI , GUIDO
Interleukin-15 (IL-15) enhances the effector mechanisms of anti-HIV immune responses and thus is considered a potential adjuvant of HIV-1 vaccine. However, there are a lack of data concerning the relationships between IL-15 expression and regulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::9af9e7d43358d3f3f6195a3eabcb6d9d
Autor:
Postorino, M. C, Prosperi, M., QUIROS ROLDAN, Maria Eugenia, Maggiolo, F., Di Giambenedetto, S., Saracino, A., Costarelli, S., Lorenzotti, S., Sighinolfi, L., Di Pietro, M., Torti, Carlo, Castelli, Francesco, Carosi, Giampiero, Nasta, Paola, Paraninfo, G., Foca', Emanuele, Torti, C., Cauda, R., Fabbiani, M., Colafigli, M., Scalzini, Alfredo, Castelnuovo, F., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Ladisa, N., Monno, L., Maggi, Paolo, Pan, A., Gori, A., Lapadula, G., Ospedale, S., Puoti, M., Viale, P., Colangeli, V., Borderi, M., Policlinico, S.
Publikováno v:
Clinical Microbiology and Infection. 21:386.e1-386.e9
Randomized trials and observational cohorts reported higher rates of virological suppression after highly active antiretroviral therapy (HAART) including efavirenz (EFV), compared with boosted protease inhibitors (PIs). Correlations with immunologica